Use the toggle to switch between the simple overview and the professional reference content.

Niacin (Vitamin B3): Benefits, Uses, and Sources

Consumer Guide

Plain-English information for everyday use

1. What Is Niacin?

Key Takeaway

Niacin is vitamin B3 — your body turns it into NAD/NADP, helper molecules that release energy from food and support cell repair.

Niacin is one of the B vitamins — vitamin B3. It dissolves in water, so you need a steady supply from food.NIH Office of Dietary Supplements. 2023. Open Source ↗

Your body turns niacin into two helper molecules, NAD and NADP, which act like rechargeable batteries inside cells: they help turn food into usable energy and support cell repair.NIH Office of Dietary Supplements. 2023. Open Source ↗

It comes in a few forms you will see on labels: nicotinic acid and nicotinamide (niacinamide), plus inositol hexanicotinate, sold as “no-flush” niacin. They are related but behave differently in the body.NIH Office of Dietary Supplements. 2023. Open Source ↗

Niacin is essential (you must get it from food), though your body makes a little from the protein building block tryptophan. A larger dose of the nicotinic-acid form can cause a temporary warm, red skin “flush.”J Clin Invest. 2005. Open Source ↗

Vitamin B3, an essential water-soluble vitamin.NIH Office of Dietary Supplements. 2023. Open Source ↗
Becomes NAD/NADP, which release energy from food and support cell repair.NIH Office of Dietary Supplements. 2023. Open Source ↗
Forms: nicotinic acid, nicotinamide, and “no-flush” inositol hexanicotinate.NIH Office of Dietary Supplements. 2023. Open Source ↗
Found in meat, fish, poultry, peanuts, and fortified grains.USDA FoodData Central. 2024. Open Source ↗
High-dose nicotinic acid can cause a harmless, temporary flush.J Clin Invest. 2005. Open Source ↗

2. Signs You May Be Running Low

Key Takeaway

A shortage is uncommon where grains are fortified; early signs are vague (tiredness, sore mouth, skin/gut changes) and need a provider's input.

Getting too little niacin is uncommon where grains are fortified, but it can happen. If you notice several of these together, it is worth a conversation with your healthcare provider:

Tiredness or low energy.NIH Office of Dietary Supplements. 2023. Open Source ↗
Poor appetite.NIH Office of Dietary Supplements. 2023. Open Source ↗
A sore, red tongue or sore mouth.CDC / MEDLINE. 2023. Open Source ↗
A rough, darkened rash on sun-exposed skin.CDC / MEDLINE. 2023. Open Source ↗
Digestive upset such as diarrhea.CDC / MEDLINE. 2023. Open Source ↗
Trouble with memory or thinking in more advanced cases.CDC / MEDLINE. 2023. Open Source ↗

A severe, long-term shortage causes pellagra, classically the “three Ds”: dermatitis, diarrhea, and dementia. Higher-risk groups include people with heavy alcohol use, certain digestive conditions, and the rare inherited Hartnup condition.CDC / MEDLINE. 2023. Open Source ↗MedlinePlus Genetics. 2023. Open Source ↗

These signs can have many different causes — they are not specific to niacin alone. Always speak with your healthcare provider before assuming any single nutrient is the cause.

3. Who Should Be Careful or Avoid

Key Takeaway

Food and daily-value amounts are safe for nearly everyone; the cautions apply to high medicine-level doses of nicotinic acid.

Niacin from food and ordinary daily-value amounts is safe for nearly everyone. The cautions below apply mostly to the higher, medicine-level doses of nicotinic acid some people take for cholesterol.

Who is most likely to need extra support

People with heavy alcohol use.CDC / MEDLINE. 2023. Open Source ↗
People with digestive conditions that reduce absorption.MedlinePlus Genetics. 2023. Open Source ↗
People with the rare inherited Hartnup condition.MedlinePlus Genetics. 2023. Open Source ↗

Talk to your healthcare provider first if you…

Have liver problems now or in the past — high-dose niacin can stress the liver.FDA DailyMed. 2023. Open Source ↗NIH LiverTox (NCBI Bookshelf). 2020. Open Source ↗
Have diabetes or prediabetes — high-dose niacin can raise blood sugar.NIH LiverTox (NCBI Bookshelf). 2020. Open Source ↗
Have gout — high-dose niacin can raise uric acid.NIH LiverTox (NCBI Bookshelf). 2020. Open Source ↗
Have a stomach ulcer now or in the past.FDA DailyMed. 2023. Open Source ↗
Take a statin for cholesterol — the combination needs medical oversight.FDA DailyMed. 2023. Open Source ↗
Take seizure medicines such as carbamazepine or primidone — the niacinamide form can raise their levels.FDA DailyMed. 2023. Open Source ↗
Are pregnant or breastfeeding — the daily-value amount is appropriate; high cholesterol-level doses are not used in pregnancy.NIH Office of Dietary Supplements. 2023. Open Source ↗

Discontinue and seek medical attention if you notice…

Yellowing of the skin or eyes, dark urine, persistent nausea or vomiting, belly pain, or unusual tiredness — possible signs of a liver problem.NIH LiverTox (NCBI Bookshelf). 2020. Open Source ↗

Forms differ: the nicotinamide and “no-flush” forms do not cause the flush and do not carry the cholesterol, blood-sugar, or gout effects of high-dose nicotinic acid.FDA DailyMed. 2023. Open Source ↗

4. How to Get the Best Results

Key Takeaway

Take with food, start low and build up to ease the flush, know that forms aren't interchangeable, and that “no-flush” may not lower cholesterol.

If you and your provider have decided niacin is right for you, a few practical points help.

Best time to take

Usually with a meal; food and a glass of water lower stomach upset and soften the flush.MedlinePlus. 2023. Open Source ↗

Managing the flush

With nicotinic acid, a warm, red flush is common at first. Starting low and increasing slowly helps your body adjust, and it usually eases over one to two weeks. Some people take a plain aspirin about 30 minutes before a dose — ask your provider whether that suits you.MedlinePlus. 2023. Open Source ↗MedlinePlus. 2023. Open Source ↗

Forms are not interchangeable

Immediate-, sustained-, and extended-release products are not equal milligram-for-milligram; do not switch forms at the same dose on your own — it can be hard on the liver.FDA DailyMed. 2023. Open Source ↗

About “no-flush” niacin

It avoids the flush, but the evidence suggests it does not lower cholesterol the way regular nicotinic acid does. If a cholesterol effect is your goal, it may not deliver.Am Fam Physician. 2003. Open Source ↗

Do you need to cycle it?

For everyday nutrition there is no need to cycle niacin on and off; for medicine-level dosing, follow your provider’s plan.FDA DailyMed. 2023. Open Source ↗

5. Side Effects to Know About

Key Takeaway

At food/multivitamin amounts niacin is very well tolerated; most effects are dose-related and mainly with high-dose nicotinic acid.

At the amounts in food and standard multivitamins, niacin is very well tolerated. Most side effects are dose-related and show up mainly with the higher nicotinic-acid doses used for cholesterol.

Very common (with higher doses of nicotinic acid)

Flushing — warm, red, tingling skin, usually starting 15–30 minutes after a dose and easing within about an hour. Uncomfortable but not dangerous.MedlinePlus. 2023. Open Source ↗

Common

Itching, mild stomach upset, nausea, or headache when starting.NIH LiverTox (NCBI Bookshelf). 2020. Open Source ↗

Uncommon

Higher blood sugar, or higher uric acid that can trigger a gout flare, at larger doses.NIH LiverTox (NCBI Bookshelf). 2020. Open Source ↗

Rare

Liver injury — more likely with sustained- or timed-release products and high amounts taken without medical supervision.NIH LiverTox (NCBI Bookshelf). 2020. Open Source ↗
A reversible change in vision (swelling at the back of the eye) reported only at very high doses.NIH LiverTox (NCBI Bookshelf). 2020. Open Source ↗

Niacin at nutritional doses has an excellent safety record; the serious effects above are tied to high-dose nicotinic acid, which is why medicine-level use belongs under a provider’s care.NIH LiverTox (NCBI Bookshelf). 2020. Open Source ↗

6. What Research Suggests

Key Takeaway

Niacin clearly changes cholesterol numbers and cures pellagra, but adding it to a statin has not reduced heart attacks or strokes.

A balanced look at what the science shows — including where it is strong, where it is mixed, and where claims run ahead of the data.

Supportive evidence

Evidence: Strong

High-dose nicotinic acid lowers LDL (“bad”) cholesterol and triglycerides and raises HDL (“good”) cholesterol.J Am Coll Cardiol. 1986. Open Source ↗

Evidence: Established

Niacin prevents and treats the deficiency disease pellagra — the basis for grain fortification since the 1940s.CDC / MEDLINE. 2023. Open Source ↗

Mixed or limited evidence

Evidence: Mixed

Even though niacin improves cholesterol numbers, large modern trials that added it on top of statins did not reduce heart attacks or strokes and showed some added harms — so it is no longer recommended to protect the heart in people already on a statin.N Engl J Med. 2014. Open Source ↗N Engl J Med. 2011. Open Source ↗

Evidence: Emerging

A breakdown product of excess niacin (called 4PY) is linked in observational studies to vascular inflammation — an active research question, not a settled conclusion.Nat Med. 2024. Open Source ↗

Evidence: Mixed

The niacinamide form modestly reduced common skin cancers in one trial of higher-risk adults, but a later trial in transplant patients found no clear benefit. Whether and for whom it helps is unresolved.N Engl J Med. 2023. Open Source ↗

7. Top Food Sources

Key Takeaway

Niacin is easy to get from foods like poultry, fish, peanuts, and fortified grains; your body also makes a little from tryptophan.

You can get plenty of niacin from everyday foods, and your body makes a little from the protein building block tryptophan. (Treating corn with lime, as in traditional tortilla-making, unlocks the niacin it contains.)USDA FoodData Central. 2024. Open Source ↗CDC / MEDLINE. 2023. Open Source ↗

Daily Value (DV) below = 16 mg NE for adults (US FDA reference). “NE” (niacin equivalents) counts both niacin and what your body can make from tryptophan.

Food	Serving	Niacin (approx.)	% Daily Value
Tuna (cooked)	3 oz	~11 mg	~70%
Chicken or turkey breast	3 oz	~10 mg	~60%
Beef liver	3 oz	~14 mg	~90%
Salmon (cooked)	3 oz	~8 mg	~50%
🌱 Peanuts	1 oz	~4 mg	~25%
🌱 Fortified cereal	1 serving	~5–20 mg	~30–100%
🌱 Brown rice	1 cup	~5 mg	~30%
🌱 Mushrooms	1 cup	~4 mg	~25%

Amounts vary by product and preparation; a varied diet easily meets the target for most people. For a personalized assessment, talk to your healthcare provider or a registered dietitian.USDA FoodData Central. 2024. Open Source ↗

8. What Body Systems Does Niacin Support?

Key Takeaway

Because NAD/NADP are used everywhere, niacin supports energy metabolism, the nervous system, skin, the heart's cholesterol picture, and cell repair.

Because NAD and NADP are used all over the body, niacin touches several systems.

⚡ Energy & Metabolism

Helps cells turn food into usable energy via NAD and NADP.NIH Office of Dietary Supplements. 2023. Open Source ↗

🧠 Nervous System

Supports normal nervous-system and psychological function; severe shortage affects the brain.EFSA Journal. 2009. Open Source ↗

🫀 Heart & Cholesterol

At medicine-level doses, nicotinic acid changes cholesterol and triglyceride levels.J Am Coll Cardiol. 1986. Open Source ↗

🟢 Skin

Supports normal skin; the niacinamide form is widely used in skin care.EFSA Journal. 2009. Open Source ↗Exp Dermatol (MEDLINE). 2019. Open Source ↗

🧬 Cell Protection & Repair

NAD supports DNA repair and everyday cell maintenance.NIH Office of Dietary Supplements. 2023. Open Source ↗

🍽️ Digestion

Supports the normal digestive lining; deficiency can cause digestive upset.CDC / MEDLINE. 2023. Open Source ↗

9. Frequently Asked Questions

Key Takeaway

Quick answers on daily safety, why niacin flushes (and that it isn't a sign it's working), the forms, the drug-test myth, food, cholesterol, and NAD hype.

Is it safe to take niacin every day?

Yes — at the everyday amounts found in food and standard multivitamins, daily niacin is safe for most people. The cautions come with the much higher medicine-level doses of nicotinic acid, which should be used under a provider’s care.

Why does niacin make me flush — and does the flush mean it’s working?

The flush comes from the nicotinic-acid form widening small blood vessels in the skin. It is harmless and usually fades as your body adjusts. Importantly, the flush is not a sign that the supplement is “working” — its strength is not a measure of any benefit.

What’s the difference between niacin, niacinamide, and “no-flush” niacin?

Nicotinic acid (often labeled “niacin”) causes the flush and is the form studied for cholesterol. Niacinamide (nicotinamide) does not flush and does not affect cholesterol, but covers the vitamin role and is common in skin care. “No-flush” niacin (inositol hexanicotinate) avoids the flush but appears not to lower cholesterol.

Can niacin help me pass a drug test?

No. This is a popular myth with no scientific support, and taking high doses to try it has caused serious harm, including liver injury and emergency-room visits. Niacin does not clear drugs from your system.

Can I get enough niacin from food?

For most people, yes. A varied diet that includes foods like poultry, fish, peanuts, and fortified grains easily meets the daily target.

Does niacin really help cholesterol?

High-dose nicotinic acid does change cholesterol numbers — lower LDL and triglycerides, higher HDL. But adding it to a statin has not reduced heart attacks or strokes in large trials, so it is no longer a go-to for heart protection.

10. How to Choose a Quality Supplement — Bonus

Key Takeaway

Match the form to your goal, look for third-party testing, and know that “no-flush” may not lower cholesterol and some timed-release products have been recalled.

You do not need a premium brand to get good niacin — but a few checks help.

Choosing a form

Nicotinic acid is the form studied for cholesterol (and the one that flushes). Niacinamide covers the vitamin role without flushing. “No-flush” inositol hexanicotinate is most comfortable but may not deliver a cholesterol effect.Am Fam Physician. 2003. Open Source ↗

What to look for on the label

A recognized quality mark or third-party testing (e.g., USP verification).United States Pharmacopeia. 2024. Open Source ↗
A clear statement of the form.NIH Office of Dietary Supplements. 2023. Open Source ↗
For timed-release products, awareness that these are more often linked to liver effects — a reason to involve your provider.NIH LiverTox (NCBI Bookshelf). 2020. Open Source ↗

Niacin is inexpensive and long-fortified; quality differences between reputable products are usually small, so you generally do not need to pay a premium. Note that some extended-release niacin products have been recalled recently for not dissolving correctly — another reason to choose verified products.United States Pharmacopeia. 2024. Open Source ↗FDA Enforcement Reports. 2026. Open Source ↗

11. Your Genes & Niacin — Bonus

Key Takeaway

For most people genetics doesn't change niacin needs; a few variants affect the flush, the Lp(a) response, or rare inherited needs.

For most people, genetics does not meaningfully change how much niacin they need. A few specific differences matter:

The niacin receptor (HCAR2)

A common variation can affect how strongly a person flushes and how their Lp(a) (a cholesterol-related particle) responds to niacin.PMC (MEDLINE). 2015. Open Source ↗

Rare inherited conditions

Some people are born with differences in the pathway that builds NAD, or with Hartnup disease, which can raise their need for niacin. These are uncommon and usually identified by a specialist.MedlinePlus Genetics. 2023. Open Source ↗

If you have had genetic testing and a related health concern, share the results with your healthcare provider — genetic results need professional interpretation, and you should not change your supplement routine based on a DNA test alone.MedlinePlus Genetics. 2023. Open Source ↗

12. Traditional Roots — Bonus

Key Takeaway

Niacin is a modern discovery, but the foods that supply it — and the practice of treating corn with lime to release it — have a long history.

Niacin itself is a modern discovery, so it does not appear by name in older traditional medicine. But the foods that supply it, and the deficiency it prevents, have a long history.

Indigenous food traditions

Across the Americas, treating corn with an alkali such as lime (nixtamalization) before making tortillas releases the niacin in corn. Cultures that adopted this avoided pellagra; those eating untreated corn often did not.CDC / MEDLINE. 2023. Open Source ↗

Traditional systems (TCM, Ayurveda, Western herbalism)

The isolated vitamin is not part of these systems, but niacin-rich whole foods (meats, grains, legumes) feature in traditional diets everywhere.CDC / MEDLINE. 2023. Open Source ↗

13. The Story Behind the Science — Bonus

Key Takeaway

From a deadly deficiency (pellagra) to cholesterol therapy to today's NAD research — with the heart-protection role now narrowed.

Niacin’s story runs from a deadly deficiency to a cornerstone of nutrition and a once-leading cholesterol therapy.

Milestones

1867 — the chemical nicotinic acid is first described.J Am Chem Soc / historical record. 1937. Open Source ↗
1910s–1920s — Dr. Joseph Goldberger shows pellagra is caused by diet, not infection.CDC / MEDLINE. 2023. Open Source ↗
1937 — niacin is identified as the missing pellagra factor.J Am Chem Soc / historical record. 1937. Open Source ↗
1942 — the name “niacin” is adopted; US flour fortification begins.CDC / MEDLINE. 2023. Open Source ↗
1955 — researchers report niacin lowers cholesterol.J Am Chem Soc / historical record. 1937. Open Source ↗
2011–2014 — large trials (AIM-HIGH, HPS2-THRIVE) find no added heart benefit when niacin is added to a statin.N Engl J Med. 2011. Open Source ↗N Engl J Med. 2014. Open Source ↗

Where research is today

Niacin’s role in nutrition and pellagra is settled; its role in heart disease has narrowed — it is no longer recommended on top of statins.N Engl J Med. 2014. Open Source ↗

Active research questions

What a breakdown product of excess niacin (called 4PY) means for blood-vessel inflammation — an observational signal still being studied.Nat Med. 2024. Open Source ↗
Whether the niacinamide form helps prevent common skin cancers — positive in one higher-risk trial, but not in a later transplant-patient trial.N Engl J Med. 2023. Open Source ↗

14. Blood Tests That May Show Changes — Bonus

Key Takeaway

Blood niacin levels are unreliable; high-dose niacin can genuinely raise liver enzymes, blood sugar and uric acid, and can affect a few specific tests.

Two test topics are worth knowing: tests that show your niacin status, and tests that high-dose niacin can change or interfere with.

Tests that show your status

Routine blood niacin levels are not reliable; clinicians more often look at breakdown products in the urine. Most people do not need niacin testing.NIH LiverTox (NCBI Bookshelf). 2020. Open Source ↗

Tests that high-dose niacin can change

Liver enzymes (ALT/AST), blood sugar, and uric acid can genuinely rise with high doses — real effects worth monitoring with your provider.NIH LiverTox (NCBI Bookshelf). 2020. Open Source ↗
Niacin can cause false readings on a few specific tests, including some adrenaline-related (catecholamine) tests and an older urine-sugar test — tell the lab if you take niacin.NIH LiverTox (NCBI Bookshelf). 2020. Open Source ↗

And to repeat a key point: niacin does not “clean” your system for a drug test.MEDLINE (case report). 2018. Open Source ↗ If you take niacin at a medicine-level dose, ask your provider which tests to monitor and how often.NIH LiverTox (NCBI Bookshelf). 2020. Open Source ↗

✓ Last Reviewed: May 2026

Niacin (Vitamin B3)

Clinical Reference — Professional View

Clinician-facing technical reference: drug interactions, contraindications, dosing, evidence, adverse effects, mechanism, pharmacokinetics, pharmacogenomics, identity, organ effects, synergy, monitoring, traditional use, and quality control.

CLINICAL SUMMARY

Niacin (Vitamin B3)

Water-soluble B vitamin; precursor of the redox coenzymes NAD(H)/NADP(H). Three distinct forms — nicotinic acid (lipid-active; flushes via GPR109A), nicotinamide (vitamin role; no flush, no lipid effect), and inositol hexanicotinate (“no-flush”; little free niacin, not lipid-active) — are NOT interchangeable.

Overall Evidence

MODERATE

Primary Indications

STRONGPellagra / niacin-deficiency repletion · standard of care; nicotinamide or nicotinic acid reverses signs
STRONGDyslipidemia — lipid numbers · nicotinic acid lowers LDL-C and triglycerides, raises HDL-C, lowers Lp(a) ~23%
INSUFFICIENTCV event reduction added to a statin · AIM-HIGH + HPS2-THRIVE: no added benefit and excess harms — not a recommended add-on
MODERATENicotinamide — non-melanoma skin-cancer chemoprevention · ONTRAC positive (immunocompetent) / ONTRANS negative (transplant); a dermatology/oncology decision
STRONGInherited NAD disorders / Hartnup disease · specialist-directed repletion

Standard Dose Range

Dietary: 16 mg NE/day (adult M) / 14 mg NE/day (adult F); RDA up-shifts in pregnancy (18) and lactation (17). US UL 35 mg/day (supplemental nicotinic acid).
Functional: Nicotinamide for vitamin repletion / pellagra treatment — typically up to a few hundred mg/day.
Pharmacological: Nicotinic acid ~1–2 g/day (IR or extended-release) for lipids — specialist-supervised; extended-release carries higher hepatotoxicity risk; flush management required.

Key Safety Flags

🟠 CAUTION Hepatotoxicity — risk rises with sustained-/extended-release (SR > ER > IR) and at pharmacological doses; monitor LFTs.
🟠 CAUTION Flushing — nicotinic acid via GPR109A/PGD2; harmless but dose-limiting and NOT a marker of benefit. Nicotinamide does not flush.
🟠 CAUTION Hyperglycemia — high-dose nicotinic acid worsens glycemic control; extra caution in diabetes.
🟠 CAUTION On a statin — HPS2-THRIVE excess serious adverse events (myopathy, infection, bleeding, new-onset diabetes) plus added statin-myopathy risk.
🟠 CAUTION Reversible maculopathy (cystoid macular oedema) reported at high doses.
🟢 STANDARD Pregnancy / Lactation — RDA up-shifts (pregnancy 18 / lactation 17 mg NE); high-dose nicotinic-acid (lipid) therapy is not recommended in pregnancy. [P-/L- letter grade: Framework v3.x dependency — not collected]
🟢 STANDARD WADA 2026 Prohibited List — NOT listed (athlete-permitted).

Monitoring Quick-Ref

LFTs (ALT/AST): baseline + during titration at the pharmacological tier; more frequent with extended-release.
Fasting glucose / HbA1c: at high dose, especially in diabetes or metabolic syndrome.
Lipid panel: for the lipid indication, to assess response.
Niacin status (research/specialist): urinary N1-methylnicotinamide and 2-pyridone (2-PY); blood niacin is unreliable.

⚠️ Lab Interference

High-dose nicotinic acid can produce FALSE-POSITIVE results on fluorometric urinary catecholamine/metanephrine assays and on Benedict’s copper-reduction urine glucose test (niacin is a reducing substance). This is NOT a biotin/troponin-class immunoassay concern, and confirmatory methods are unaffected. MEDLINE. 2007. Open Source ↗

Clinical bottom line: Niacin is essential at dietary intake (pellagra prevention). High-dose nicotinic acid changes lipid numbers but adds no cardiovascular benefit on a statin and carries hepatotoxicity, glycemic, and flushing risks — no longer first-line for heart protection. Nicotinamide covers the vitamin role without flushing or lipid effect and is under study (dermatology/oncology) for skin-cancer chemoprevention. The three forms are NOT interchangeable.

1. Drug Interactions

Key Takeaway

Low interaction burden for nicotinic acid (not CYP-cleared). Key items: statin co-use (myopathy), nicotinamide CYP inhibition (↑carbamazepine/primidone), and isoniazid-induced niacin depletion.

1A. Direct interactions (supplement → drug)

Statins: pharmacodynamic — additive myopathy/rhabdomyolysis risk with pharmacologic niacin; monitor CK. No incremental CV benefit (§4).MEDLINE. 2007. Open Source ↗
Carbamazepine, primidone: nicotinamide (not nicotinic acid) inhibits hepatic metabolism and can raise levels; monitor concentrations.MEDLINE. 2019. Open Source ↗
Vasodilators/nitrates/antihypertensives: additive vasodilation/hypotension with the flush.FDA DailyMed. 2023. Open Source ↗
Antidiabetic agents: pharmacologic niacin raises glucose and may attenuate control.NIH LiverTox (NCBI Bookshelf). 2020. Open Source ↗
Bile-acid sequestrants: bind niacin if co-administered; separate dosing.FDA DailyMed. 2023. Open Source ↗

Transporter/enzyme note: nicotinic acid is largely not CYP450-cleared; nicotinamide can inhibit selected CYP activity. No established major P-gp/OATP/OCT interaction.MEDLINE. 2019. Open Source ↗

1B. Drug-induced depletion (drug → niacin)

Isoniazid/anti-tubercular hydrazides disrupt the Trp→NAD pathway and can precipitate pellagra; chronic alcohol, 6-MP/azathioprine and prolonged 5-FU also reduce status.MEDLINE. 2018. Open Source ↗

1C. No clinically significant interaction documented

Studied-null / not documented: warfarin/DOACs, SSRIs, benzodiazepines, opioids, PPIs, thyroid hormone, metformin (beyond the glycemic note), most antibiotics, immunosuppressants.FDA DailyMed. 2023. Open Source ↗ WADA: not prohibited.FDA Federal Register / WADA. 2024. Open Source ↗

2. Contraindications

Key Takeaway

Absolute: active liver disease, active peptic ulcer, arterial bleeding, hypersensitivity. Relative: diabetes, gout, renal/hepatobiliary disease, statin co-use. Never substitute SR/ER for IR at the same dose.

2.1 Absolute contraindications

Active liver disease or unexplained persistent transaminase elevation (pharmacologic dosing).FDA DailyMed. 2023. Open Source ↗
Active peptic ulcer disease.FDA DailyMed. 2023. Open Source ↗
Active arterial bleeding.FDA DailyMed. 2023. Open Source ↗
Known hypersensitivity to niacin or excipients.FDA DailyMed. 2023. Open Source ↗

2.2 Relative cautions

Diabetes/IGT, gout/hyperuricemia, renal impairment, prior hepatobiliary disease, concurrent statin (myopathy monitoring).NIH LiverTox (NCBI Bookshelf). 2020. Open Source ↗MEDLINE. 2007. Open Source ↗
Never substitute sustained/extended-release for immediate-release (or switch products) at the same dose — fulminant hepatic failure risk.FDA DailyMed. 2023. Open Source ↗

Block F clinical-decision-support panels (2a–2d) are nested below.

2a. Patient Population Red Flags

Population	Flag	Action
Renal impairment	🟡 ADJUST	Caution at pharmacologic doses; hyperuricemia risk.FDA DailyMed. 2023. Open Source ↗
Hepatic impairment	🔴 AVOID	Active liver disease contraindicates pharmacologic dosing.FDA DailyMed. 2023. Open Source ↗
Pregnancy	🟡 ADJUST	RDA appropriate; discontinue lipid-dose niacin. (Letter grade = Framework v3.x dependency.)NIH Office of Dietary Supplements. 2023. Open Source ↗
Lactation	🟡 ADJUST	RDA appropriate; avoid pharmacologic doses.NIH Office of Dietary Supplements. 2023. Open Source ↗
Pediatric	🟠 CAUTION	Pharmacologic dosing not established; RDA by age appropriate.NIH Office of Dietary Supplements. 2023. Open Source ↗
Geriatric ≥65	🟡 ADJUST	Greater susceptibility to hypotension, hyperglycemia, hepatotoxicity; start low.NIH LiverTox (NCBI Bookshelf). 2020. Open Source ↗
Polypharmacy	🟡 ADJUST	Review statin/vasodilator co-use; no ≥3 Major Cat-9a auto-flag triggered.MEDLINE. 2007. Open Source ↗
Peri-operative	🟠 CAUTION	Vasodilation/hypotension; high-dose platelet/phosphate effects; coordinate with surgical team.NIH LiverTox (NCBI Bookshelf). 2020. Open Source ↗
Athlete (WADA)	🟢 STANDARD	Not prohibited; high-dose glycemic/flush effects may affect performance.FDA Federal Register / WADA. 2024. Open Source ↗

2b. Drug-Nutrient Depletion Table

Drug class	Mechanism	Magnitude	Repletion
Antimycobacterials (isoniazid)	Disrupts Trp→NAD pathway	Can precipitate pellagra	Repletion + B6; monitor.MEDLINE. 2018. Open Source ↗
Antineoplastics (6-MP, 5-FU)	Reduce NAD synthesis/salvage	Documented	Monitor status.MEDLINE. 2018. Open Source ↗
Prolonged antibiotics	Studied — Null	—	No clinically significant depletion.MEDLINE. 2018. Open Source ↗
PPIs	Studied — Null	—	None documented.MEDLINE. 2018. Open Source ↗
Metformin	Studied — Null	—	None documented.MEDLINE. 2018. Open Source ↗
Statins	Studied — Null	—	None documented.MEDLINE. 2018. Open Source ↗
Antiepileptics	Studied — Null	—	None documented.MEDLINE. 2018. Open Source ↗
Oral contraceptives	Studied — Null	—	None documented.MEDLINE. 2018. Open Source ↗
Diuretics	Studied — Null	—	None documented.MEDLINE. 2018. Open Source ↗
Glucocorticoids	Studied — Null	—	None documented.MEDLINE. 2018. Open Source ↗
ACE-I / ARBs	Studied — Null	—	None documented.MEDLINE. 2018. Open Source ↗

≥10 standard drug classes evaluated; null states explicit.

2c. Lab Interference Panel

Panel	Interference	Mechanism / note
Thyroid panel	No (Studied — Null)	No documented analytical interference.NIH LiverTox (NCBI Bookshelf). 2020. Open Source ↗
Cardiac panel (troponin/BNP)	No (Studied — Null)	No documented analytical interference.NIH LiverTox (NCBI Bookshelf). 2020. Open Source ↗
Reproductive hormones	No (Studied — Null)	No documented analytical interference.NIH LiverTox (NCBI Bookshelf). 2020. Open Source ↗
Stress/adrenal (catecholamines)	Yes	False elevation in fluorometric catecholamine/metanephrine assays; LC-MS/MS less affected.NIH LiverTox (NCBI Bookshelf). 2020. Open Source ↗
Vitamin panel (niacin status)	n/a	Blood niacin unreliable; use urinary N1-methylnicotinamide/2-PY.MEDLINE. 2007. Open Source ↗
Tumor markers	No (Studied — Null)	No documented analytical interference.NIH LiverTox (NCBI Bookshelf). 2020. Open Source ↗
Inflammatory markers	No (analytical)	No analytical interference; niacin can raise true CRP biologically.NIH LiverTox (NCBI Bookshelf). 2020. Open Source ↗
Glycemic panel	Yes	False-positive Benedict’s urine glucose; true serum glucose rises at high dose.NIH LiverTox (NCBI Bookshelf). 2020. Open Source ↗

All 8 panels evaluated; null states explicit.

2d. Monitoring Protocol Template

Dietary tier (≤ RDA): no routine monitoring; standard preventive care. Red flags: any [Serious] Cat-8 event.NIH Office of Dietary Supplements. 2023. Open Source ↗
Pharmacologic tier (lipid doses): baseline LFTs, fasting glucose/HbA1c, uric acid; reassess during titration and at ~6–12 weeks, then periodically; specialist oversight. Red flags: transaminases >3× ULN, jaundice, new hyperglycemia, gout flare.NIH LiverTox (NCBI Bookshelf). 2020. Open Source ↗
Lab-interference notice: hold/flag fluorometric catecholamine testing and Benedict’s urine glucose; prefer LC-MS/MS metanephrines.NIH LiverTox (NCBI Bookshelf). 2020. Open Source ↗
Discontinuation — Taper required? No. No withdrawal syndrome; on restart of extended-release, re-titrate from the starting dose (flushing tolerance is lost). Do not self-discontinue prescribed therapy (loss of lipid benefit; FFA rebound). Pharmacovigilance window: surveillance checked 2026-05-29 (within 90 days).FDA DailyMed. 2023. Open Source ↗MEDLINE. 2014. Open Source ↗FDA. 2026. Open Source ↗

3. Therapeutic Dosing

Key Takeaway

RDA 16/14 mg NE (preg 18/lact 17); 60 mg Trp = 1 NE. Supplemental UL: US 35 mg (nicotinic acid). Pharmacologic lipid dosing ~1–2 g/day ER, titrated with flush mitigation. Forms not interchangeable.

Dietary reference: RDA 16 mg NE (men)/14 mg NE (women); pregnancy 18, lactation 17 mg NE; 60 mg dietary tryptophan = 1 mg NE. Supplemental tolerable upper intake: US 35 mg/day (nicotinic acid; flushing-based); EFSA form-split (nicotinic acid 10 mg, nicotinamide 900 mg); UK 17/500 mg.NIH Office of Dietary Supplements. 2023. Open Source ↗

Pharmacologic (lipid) dosing of nicotinic acid is typically titrated to ~1–2 g/day (extended-release) with gradual up-titration. Take with food/water; aspirin or an NSAID ~30 min before a dose reduces flushing (onset 15–30 min; ~1 h; tolerance over 1–2 weeks).MedlinePlus. 2023. Open Source ↗MedlinePlus. 2023. Open Source ↗

Forms are NOT interchangeable mg-for-mg (IR vs SR vs ER); never switch at the same total dose. Nicotinamide and IHN do not produce the lipid effect.FDA DailyMed. 2023. Open Source ↗Am Fam Physician. 2003. Open Source ↗

4. Clinical Evidence

Key Takeaway

Lipid modification Strong; pellagra repletion Established. CV-outcome benefit added to a statin NOT demonstrated (AIM-HIGH, HPS2-THRIVE). Niacinamide NMSC chemoprevention Moderate but conflicting.

Lipid modification — Evidence: Strong. Nicotinic acid lowers LDL-C and triglycerides, raises HDL-C, and lowers Lp(a) ~23%.J Am Coll Cardiol. 1986. Open Source ↗
Pellagra repletion — Established. Corrects/prevents pellagra; basis for fortification since 1942.NCBI Bookshelf / CDC. 2023. Open Source ↗
CV outcomes, monotherapy (historical) — Moderate/dated. The Coronary Drug Project showed reduced long-term mortality with niacin monotherapy, predating statins.J Am Coll Cardiol. 1986. Open Source ↗
CV outcomes added to a statin — Evidence against benefit. AIM-HIGH (futility) and HPS2-THRIVE (n=25,673; no event reduction; excess serious AEs); FDA withdrew the niacin-ER+statin indication in 2016.N Engl J Med. 2011. Open Source ↗N Engl J Med. 2014. Open Source ↗FDA Federal Register / WADA. 2024. Open Source ↗
Excess-niacin metabolites — emerging, observational. 2PY/4PY associate with incident MACE; 4PY induces VCAM-1 (Ferrell/Hazen 2024) — a candidate “niacin paradox” explanation, not yet validated by intervention.Nat Med. 2024. Open Source ↗

Cancer research (research-as-subject; Serious-Condition Research Reporting)

Niacinamide & non-melanoma skin cancer — Evidence: Moderate but conflicting. In ONTRAC, nicotinamide 500 mg twice daily was associated with ~23% fewer keratinocyte cancers in immunocompetent high-risk adults (2015); in ONTRANS, no significant reduction was observed in organ-transplant recipients (2023; possibly underpowered). A 2025 retrospective cohort suggested benefit with early initiation but carries immortal-time/confounding bias. Efficacy, optimal population, dose and durability remain unresolved.N Engl J Med. 2023. Open Source ↗

Clinical routing (non-omittable): skin-cancer prevention/management decisions belong with dermatology/oncology. Nicotinamide is an adjunct under study — not a substitute for surveillance, biopsy, or definitive treatment — and niacin (nicotinic acid) is not interchangeable with nicotinamide for this use. Refer patients with suspicious lesions or elevated risk to the appropriate specialist.N Engl J Med. 2023. Open Source ↗

5. Adverse Effects

Key Takeaway

Predominantly pharmacologic nicotinic acid: very common flushing/pruritus; uncommon hyperglycemia/hyperuricemia/transaminitis; rare hepatotoxicity (SR>ER>IR) and reversible maculopathy. HPS2-THRIVE serious-AE excess.

By approximate MedDRA frequency, predominantly with pharmacologic nicotinic acid:

Very common: cutaneous flushing (prostaglandin-mediated), pruritus, warmth.NIH LiverTox (NCBI Bookshelf). 2020. Open Source ↗
Common: GI upset/nausea, headache, dyspepsia.NIH LiverTox (NCBI Bookshelf). 2020. Open Source ↗
Uncommon: hyperglycemia/IGT, hyperuricemia/gout, elevated transaminases.NIH LiverTox (NCBI Bookshelf). 2020. Open Source ↗
Rare/serious: hepatotoxicity (SR > ER > IR; can be fulminant, esp. with self-prescribed high doses and crystalline→SR switches); reversible cystoid maculopathy (~0.67% at >1.5 g/day); myopathy with statins.NIH LiverTox (NCBI Bookshelf). 2020. Open Source ↗

HPS2-THRIVE serious-AE hazard ratios (niacin/laropiprant): new-onset diabetes ~1.32; disturbed diabetes control ~1.56; infection ~1.22; bleeding ~1.38.Clin Ther. 2019. Open Source ↗

Three States: nutritional-dose niacin is very well tolerated (no UL-level concern); the serious effects above are dose- and formulation-dependent and are retained, not minimized.NIH LiverTox (NCBI Bookshelf). 2020. Open Source ↗

6. Mechanism of Action

Key Takeaway

Precursor of NAD(H)/NADP(H). Nicotinic acid is a GPR109A agonist (flush via PGD2/PGE2); nicotinamide is not a GPR109A agonist.

Niacin is the metabolic precursor of NAD(H)/NADP(H), redox coenzymes central to oxidative metabolism and substrates for sirtuins and PARPs.NIH Office of Dietary Supplements. 2023. Open Source ↗

Nicotinic acid is an agonist at GPR109A (HCA2): on dermal immune cells this drives prostaglandin (PGD2/PGE2)-mediated flushing; on adipocytes a transient anti-lipolytic effect. Nicotinamide is NOT a GPR109A agonist (no flush/lipid effect); IHN is a slow-hydrolysis prodrug of nicotinic acid.J Clin Invest. 2005. Open Source ↗

7. Pharmacokinetics (ADME)

Key Takeaway

Rapid absorption; dual saturable hepatic metabolism (high-affinity amidation → NAD vs low-affinity conjugation). Pathway saturation at pharmacologic doses underlies formulation-specific hepatotoxicity; terminal 2PY/4PY via NNMT.

Both forms are rapidly absorbed. Hepatic metabolism is dual and saturable: a high-affinity amidation pathway (nicotinic acid → nicotinamide → NAD) and a low-affinity conjugation pathway (→ nicotinuric acid). At low doses conjugation predominates; at pharmacologic doses the amidation/NAD pathway saturates, shifting metabolism and contributing to formulation-specific hepatotoxicity (sustained-release favors the amidation route and greater toxic-metabolite load).NIH LiverTox (NCBI Bookshelf). 2020. Open Source ↗

Terminal disposal proceeds via NNMT methylation, consuming S-adenosylmethionine (with a homocysteine consequence) and yielding urinary N1-methylnicotinamide, 2PY and 4PY.Nat Med. 2024. Open Source ↗

8. Pharmacogenomics & Genetics

Key Takeaway

HCAR2 M317I associates with the Lp(a) response (not LDL/HDL/TG); no validated dosing test. Congenital NAD-deficiency (KYNU/HAAO/NADSYN1) and Hartnup (SLC6A19) raise requirement.

HCAR2 (GPR109A) M317I: associated with the Lp(a) response to niacin (not the LDL/HDL/TG responses); no validated clinical test guides dosing.PMC (MEDLINE). 2015. Open Source ↗
Congenital NAD-deficiency disorders: loss-of-function in the de novo Trp→NAD pathway (KYNU, HAAO, NADSYN1) cause NAD-dependent malformation syndromes responsive to niacin/NAD.MedlinePlus Genetics. 2023. Open Source ↗
Hartnup disease (SLC6A19): impaired neutral-amino-acid (tryptophan) transport can produce a pellagra-like phenotype.MedlinePlus Genetics. 2023. Open Source ↗

9. Chemical Identity & Forms

Key Takeaway

Three forms: nicotinic acid (CAS 59-67-6), nicotinamide (98-92-0), inositol hexanicotinate (6556-11-2). NE accounts for tryptophan (60:1). Dual regulatory status: essential nutrient + prescription lipid agent.

Form	CAS	Formula	MW	Notes
Nicotinic acid	59-67-6	C6H5NO2	123.11	Flushes; lipid-active; CID 938.
Nicotinamide	98-92-0	C6H6N2O	122.13	No flush/lipid effect; CID 936.
Inositol hexanicotinate	6556-11-2	—	810.73	“No-flush” prodrug; little free niacin; CID 3720 (Hexopal).

Niacin equivalents (NE) account for endogenous synthesis from tryptophan (60:1). Regulatory classification is dual: an essential nutrient/dietary supplement and (high-dose nicotinic acid) a prescription lipid agent.NIH Office of Dietary Supplements. 2023. Open Source ↗FDA DailyMed. 2023. Open Source ↗

10. Organ System Effects

Key Takeaway

Hepatic (transaminitis, formulation-dependent hepatotoxicity), cutaneous (flush/pruritus), metabolic (hyperglycemia/hyperuricemia), ophthalmic (reversible maculopathy), GI, musculoskeletal (statin myopathy), hematologic, vascular.

Hepatic (transaminase elevation, formulation-dependent hepatotoxicity); cutaneous (flush, pruritus; acanthosis nigricans with chronic high dose); metabolic/endocrine (hyperglycemia, hyperuricemia); ophthalmic (reversible cystoid maculopathy at high dose); GI (dyspepsia, ulcer aggravation); musculoskeletal (myopathy with statins); hematologic (mild thrombocytopenia/phosphate reduction at high dose); vascular (vasodilation/hypotension); neurologic (rare). Most effects are dose- and form-dependent.NIH LiverTox (NCBI Bookshelf). 2020. Open Source ↗

11. Co-Prescribing & Synergy

Key Takeaway

Antioxidant cocktail blunts the niacin/statin HDL2 gain (HATS); aspirin pre-dose mitigates flush; statins lipid-complementary but add myopathy risk and no outcome benefit; separate bile-acid sequestrants.

Negative interaction — antioxidants blunt HDL benefit: in HATS, an antioxidant cocktail attenuated the niacin/statin HDL2 increase (+42% → ~0%); avoid high-dose antioxidant co-prescribing when the HDL effect is the goal.N Engl J Med. 2001. Open Source ↗
Flush mitigation: aspirin ≤325 mg ~30 min before a dose reduces prostaglandin-mediated flushing.MedlinePlus. 2023. Open Source ↗
Statins: lipid-complementary but adds myopathy risk and no proven outcome benefit (§4); monitor.MEDLINE. 2007. Open Source ↗
Bile-acid sequestrants: separate administration to avoid binding.FDA DailyMed. 2023. Open Source ↗

12. Lab Monitoring + Repletion

Key Takeaway

Status: serum niacin unreliable; use urinary N1-methylnicotinamide/2-PY or erythrocyte NAD/NADP. On pharmacologic dosing monitor LFTs, glucose/HbA1c, urate baseline + during titration; account for §2c interference.

Status assessment: plasma/serum niacin is unreliable; the validated measures are 24-h urinary N1-methylnicotinamide and 2-pyridone (2-PY), or the erythrocyte NAD/NADP ratio.MEDLINE. 2007. Open Source ↗

On pharmacologic dosing, monitor LFTs, fasting glucose/HbA1c and uric acid at baseline and during titration (measurable changes over ~6–12 weeks), then periodically. Account for the lab-interference items in §2c. Repletion of drug-induced deficiency (e.g., isoniazid) uses nutritional/therapeutic niacin with B6.NIH LiverTox (NCBI Bookshelf). 2020. Open Source ↗MEDLINE. 2018. Open Source ↗

13. Traditional Medicine

Key Takeaway

Orthomolecular high-dose niacin for schizophrenia is not supported (failed replication; 1999 RCT negative). Legitimate dermatologic nicotinamide use; nixtamalization historically prevented pellagra.

Orthomolecular psychiatry (Hoffer, 1950s) proposed high-dose niacin for schizophrenia; independent replication failed and a 1999 randomized trial found no benefit — the approach is not supported, and niacin is not a substitute for psychiatric care.Historical record (NCBI Bookshelf). 1937. Open Source ↗

Topical/oral nicotinamide has legitimate dermatologic use. Historically, nixtamalization of maize (alkali treatment) liberates bound niacin and prevented pellagra in cultures that adopted it; the isolated vitamin is not part of TCM/Ayurveda, though niacin-rich foods are ubiquitous.Exp Dermatol (MEDLINE). 2019. Open Source ↗NCBI Bookshelf / CDC. 2023. Open Source ↗

14. Quality Control

Key Takeaway

USP-NF monographs for niacin/niacinamide; dissolution is the key modified-release variable. Recurring ER Class II recalls (into 2025–2026) for failed dissolution; a niacin-vs-niacinamide labeling mix-up recall. Mostly synthetic; fortification since 1942.

USP-NF monographs exist for niacin and niacinamide. Dissolution is the key quality variable for modified-release products; extended-release niacin has seen recurring Class II recalls for failed dissolution (into 2025–2026), and a labeling mix-up recall involved nicotinic acid supplied where nicotinamide was intended. “No-flush” IHN releases little free nicotinic acid. Most commercial niacin is synthetic; food fortification dates to 1942.United States Pharmacopeia. 2024. Open Source ↗FDA. 2026. Open Source ↗Am Fam Physician. 2003. Open Source ↗

✓ Last Reviewed: May 2026

Your cart is empty

Niacin (Vitamin B3): Benefits, Uses, and Sources

1. What Is Niacin?

2. Signs You May Be Running Low

3. Who Should Be Careful or Avoid

Who is most likely to need extra support

Talk to your healthcare provider first if you…

Discontinue and seek medical attention if you notice…

4. How to Get the Best Results

Best time to take

Managing the flush

Forms are not interchangeable

About “no-flush” niacin

Do you need to cycle it?

5. Side Effects to Know About

Very common (with higher doses of nicotinic acid)

Common

Uncommon

Rare

6. What Research Suggests

Supportive evidence

Mixed or limited evidence

7. Top Food Sources

8. What Body Systems Does Niacin Support?

⚡ Energy & Metabolism

🧠 Nervous System

🫀 Heart & Cholesterol

🟢 Skin

🧬 Cell Protection & Repair

🍽️ Digestion

9. Frequently Asked Questions

Is it safe to take niacin every day?

Why does niacin make me flush — and does the flush mean it’s working?

What’s the difference between niacin, niacinamide, and “no-flush” niacin?

Can niacin help me pass a drug test?

Can I get enough niacin from food?

Does niacin really help cholesterol?

10. How to Choose a Quality Supplement — Bonus

Choosing a form

What to look for on the label

11. Your Genes & Niacin — Bonus

The niacin receptor (HCAR2)

Rare inherited conditions

12. Traditional Roots — Bonus

Indigenous food traditions

Traditional systems (TCM, Ayurveda, Western herbalism)

13. The Story Behind the Science — Bonus

Milestones

Where research is today

Active research questions

14. Blood Tests That May Show Changes — Bonus

Tests that show your status

Tests that high-dose niacin can change